The European Health Union is implementing a reform to improve access, affordability, and innovation in the pharmaceutical industry. The reform aims to create a single market for drugs, deliver medications faster, provide equal access to medicines, eliminate drug shortages, promote an innovative and competitive sector, and make medicines more environmentally sustainable. The reform encourages an innovation-friendly environment, faster authorization processes, and transparency in public funding for drug development. It addresses challenges in accessing medicines, inequalities between countries, and high drug prices. The goal is to ensure EU patients have timely, equitable, and affordable access to medicines.